APR 16, 2015 09:27 AM PDT

Tumor-Only Genetic Sequencing May Mislead Cancer Therapy

When it comes to sequencing patients' tumor genomes to personalize cancer therapy, one very important step may be missing, suggest Johns Hopkins researchers: a point of comparison to patients' noncancerous genomes.
Johns Hopkins researchers cite the importance of comparing patients' cancerous and noncancerous genomes.
Without these comparisons - or a full picture of a patient's genome - nearly half of all patients may be getting the wrong cancer treatment, say the researchers at the John Hopkins Kimmel Cancer Center.

"By not sequencing each person's normal tissue to filter out noncancer-related changes, it's difficult to really understand what is occurring in the tumor," said Victor Velculescu, M.D., Ph.D., a professor of oncology and pathology and co-director of the Cancer Biology Program at the Johns Hopkins University School of Medicine, in a press release.

The study appears today in Science Translational Medicine.

When Velculescu and colleagues compared the genomes of tumor and normal tissue from more than 800 cancer patients' sequencing data, they found that approximately 65 percent of the genetic changes identified with tumor-only genetic sequencing were "false positives" and not related to the patient's cancer. That's because, by first sequencing a patient's noncancer genome, the researchers identified which genetic changes are heritable variations.

The researchers also looked at changes in "actionable genes," or genes for which some drug or therapy has been identified. In this case, false positive affected 48 percent of the patients analyzed.

"In tumor-only analyses, we found that nearly half of patients had tumor mutations that were actually germline or false positives in actionable genes, and they could lead to inappropriate therapy," Velculescu said.

Inaccurate genetic information can lead to side effects from incorrect targeted therapies and increased costs of patient care from misdirected medicines, report the researchers.

That said, Velculescu and his team acknowledge the challenges associated with implementing tumor-normal analyses in a clinical setting - including added costs of sequencing a patient's normal tissue.

These study results build on the concept of precision medicine, in which oncology researchers hope that one day, DNA sequencing will be a reality for every cancer patient, so that patients may receive personalized therapy.

By Stephanie Guzowski, Editor, Drug Discovery News
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
AUG 10, 2018
Immunology
AUG 10, 2018
Cancer Cell 'Drones' Battle Immune System
Cancer cells release PD-L1 containing exosomes that circulate in the blood and stop T cells before they can reach tumors....
AUG 30, 2018
Genetics & Genomics
AUG 30, 2018
Genetic Changes can Help Diagnose Childhood Cancers Far Earlier
New research has revealed genetic rearrangements that happen far before bone cancer starts growing in children....
SEP 01, 2018
Cancer
SEP 01, 2018
How eating vegetables can help prevent colon cancer?
We have always been told to eat more vegetables as they are rich in many nutrients and vitamins as well as the ability to protect us from many diseases. Re...
OCT 31, 2018
Cancer
OCT 31, 2018
Researchers identify a protein marker that induces dormancy in metastatic breast cancer
Researchers at the Mount Sinai hospital identified for the first time a protein marker that could indicate whether breast cancer will further metastasize or remains in a dormant state accordi...
NOV 12, 2018
Health & Medicine
NOV 12, 2018
Researchers find that obesity has a paradoxical effect on Cancer
Cancer therapy works differently in different people. Understanding what effects the individual body's response to treatment will be crucial for the development...
DEC 11, 2018
Cancer
DEC 11, 2018
Biosensors developed that can detect cancer's metastatic ability
Researchers in University of California San Diego School of Medicine have developed a biosensor that can detect whether a cancer cell will spread in the future or not, which will help in deve...
Loading Comments...